Schond L. Greenway Avalo Therapeutics, Inc. (AVTX) insider trading activity

Schond L. Greenway is CFO of Avalo Therapeutics, Inc.. Currently has a direct ownership of 3,883 shares of AVTX, which is worth approximately $35,335. The most recent transaction as insider was on Dec 10, 2021, when has been sold 2,231 shares (Common Stock) at a price of $1.57 per share, resulting in proceeds of $3,503. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.88K

0% 3M change

0% 12M change

Total Value Held $35,335

Schond L. Greenway Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Dec 10 2021	BUY Open market or private purchase	$3,503 $1.57 p/Share	2,231 Added 36.49%	3,883 Common Stock
Jun 10 2021	BUY Open market or private purchase	$1,747 $2.68 p/Share	652 Added 28.3%	1,652 Common Stock

Also insider at

MNMD

Mind Medicine (MindMed) Inc. Healthcare

Chief Financial Officer

SLG